INHIBITEURS DE L'INTERACTION PROTEINE-PROTEINE DU DOMAINE BCL6 BTB ET LEURS UTILISATIONS

• 收藏
• 分享

专利权人:

ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)

发明人:

AL-AWAR, RIMA,ISAAC, METHVIN,CHAU, ANH MY,MAMAI, AHMED,WATSON, IAIN,PODA, GENNADY,SUBRAMANIAN, PANDIARAJU,WILSON, BRIAN,UEHLING, DAVID,PRAKESCH, MICHAEL,JOSEPH, BABU,MORIN, JUSTIN-ALEXANDER

申请号：

CA3088025

公开号：

CA3088025A1

申请日:

2019.02.06

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present application relates to compounds of Formula I (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/